Clinical Trial Update: Molecular Pathways Involved in the Pathogenesis and Behavior of Mesenchymal Phosphaturic Tumors Causing Oncogenic Osteomalacia

View source ↗

Summary

Clinical trial update examining molecular pathways involved in mesenchymal phosphaturic tumors that cause tumor-induced osteomalacia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tumor-induced Osteomalacia

Snippet

Sponsor: AHEPA University Hospital | Conditions: Tumor Induced Oncogenic Osteomalacia | Status: UNKNOWN